Maria Pigg, Peter Svensson, Mark Drangsholt, Thomas List
{"title":"非典型牙痛患者7年随访:一项前瞻性研究。","authors":"Maria Pigg, Peter Svensson, Mark Drangsholt, Thomas List","doi":"10.11607/jop.1033","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To examine the long-term prognosis of 46 previously examined atypical odontalgia (AO) patients.</p><p><strong>Methods: </strong>In 2002 and 2009, AO patients completed validated instruments measuring pain characteristics (pain frequency and intensity), physical functioning (Graded Chronic Pain Severity, GCPS) and emotional functioning (Symptoms Checklist, SCL-90R). The main outcome was global improvement. Baseline data on quantitative somatosensory testing and responsiveness to lidocaine injection were available for a subgroup of patients. Paired tests compared baseline and follow-up data, and logistic regression explored the possible prognostic value of baseline data.</p><p><strong>Results: </strong>Data from 37 patients (80%) were obtained. Thirteen patients (35%; 95% confidence intervals [CI] 20.2%-52.5%) rated their overall pain status as significantly improved, 22 (60%; 95% CI 42.1%-75.3%) as a little improved or unchanged, and two patients (5%; 95% CI 0.7%-18.2%) as worse. Five patients (14%; 95% CI 4.5%-28.8%) were pain-free, indicated by a characteristic pain intensity score of 0. Average pain intensity decreased (from 5.7 ± 2.0 to 3.5 ± 2.4; P < .001). Pain frequency (P < .001) and GCPS (P < .001) also decreased, whereas SCL-90R scores remained unchanged and 26 of the 37 patients reported ongoing treatment. Low baseline pain intensity was the only factor predictive of favorable outcome.</p><p><strong>Conclusion: </strong>A third of the AO patients improved considerably over time, but for many of the patients, AO was a persistent and treatment-resistant condition.</p>","PeriodicalId":16649,"journal":{"name":"Journal of orofacial pain","volume":"27 2","pages":"151-64"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.11607/jop.1033","citationCount":"58","resultStr":"{\"title\":\"Seven-year follow-up of patients diagnosed with atypical odontalgia: a prospective study.\",\"authors\":\"Maria Pigg, Peter Svensson, Mark Drangsholt, Thomas List\",\"doi\":\"10.11607/jop.1033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>To examine the long-term prognosis of 46 previously examined atypical odontalgia (AO) patients.</p><p><strong>Methods: </strong>In 2002 and 2009, AO patients completed validated instruments measuring pain characteristics (pain frequency and intensity), physical functioning (Graded Chronic Pain Severity, GCPS) and emotional functioning (Symptoms Checklist, SCL-90R). The main outcome was global improvement. Baseline data on quantitative somatosensory testing and responsiveness to lidocaine injection were available for a subgroup of patients. Paired tests compared baseline and follow-up data, and logistic regression explored the possible prognostic value of baseline data.</p><p><strong>Results: </strong>Data from 37 patients (80%) were obtained. Thirteen patients (35%; 95% confidence intervals [CI] 20.2%-52.5%) rated their overall pain status as significantly improved, 22 (60%; 95% CI 42.1%-75.3%) as a little improved or unchanged, and two patients (5%; 95% CI 0.7%-18.2%) as worse. Five patients (14%; 95% CI 4.5%-28.8%) were pain-free, indicated by a characteristic pain intensity score of 0. Average pain intensity decreased (from 5.7 ± 2.0 to 3.5 ± 2.4; P < .001). Pain frequency (P < .001) and GCPS (P < .001) also decreased, whereas SCL-90R scores remained unchanged and 26 of the 37 patients reported ongoing treatment. Low baseline pain intensity was the only factor predictive of favorable outcome.</p><p><strong>Conclusion: </strong>A third of the AO patients improved considerably over time, but for many of the patients, AO was a persistent and treatment-resistant condition.</p>\",\"PeriodicalId\":16649,\"journal\":{\"name\":\"Journal of orofacial pain\",\"volume\":\"27 2\",\"pages\":\"151-64\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.11607/jop.1033\",\"citationCount\":\"58\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of orofacial pain\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11607/jop.1033\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of orofacial pain","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11607/jop.1033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 58
摘要
目的:探讨46例非典型牙痛(AO)患者的长期预后。方法:2002年和2009年,AO患者完成了疼痛特征(疼痛频率和强度)、身体功能(慢性疼痛严重程度分级,GCPS)和情绪功能(症状检查表,SCL-90R)的测试。主要成果是全球改善。定量体感测试和对利多卡因注射反应性的基线数据可用于一个亚组患者。配对试验比较基线和随访数据,逻辑回归探讨基线数据可能的预后价值。结果:获得37例(80%)患者资料。13例(35%;95%可信区间[CI] 20.2%-52.5%)认为他们的整体疼痛状况显著改善,22 (60%;95% CI 42.1%-75.3%)略有改善或不变,2例患者(5%;95% CI为0.7%-18.2%)。5例患者(14%;95% CI 4.5%-28.8%)无痛,特征性疼痛强度评分为0。平均疼痛强度下降(从5.7±2.0降至3.5±2.4;P < 0.001)。疼痛频率(P < 0.001)和GCPS (P < 0.001)也下降,而SCL-90R评分保持不变,37例患者中有26例报告正在接受治疗。低基线疼痛强度是预测预后良好的唯一因素。结论:三分之一的AO患者随着时间的推移有了明显的改善,但对许多患者来说,AO是一种持续的、难治性的疾病。
Seven-year follow-up of patients diagnosed with atypical odontalgia: a prospective study.
Aims: To examine the long-term prognosis of 46 previously examined atypical odontalgia (AO) patients.
Methods: In 2002 and 2009, AO patients completed validated instruments measuring pain characteristics (pain frequency and intensity), physical functioning (Graded Chronic Pain Severity, GCPS) and emotional functioning (Symptoms Checklist, SCL-90R). The main outcome was global improvement. Baseline data on quantitative somatosensory testing and responsiveness to lidocaine injection were available for a subgroup of patients. Paired tests compared baseline and follow-up data, and logistic regression explored the possible prognostic value of baseline data.
Results: Data from 37 patients (80%) were obtained. Thirteen patients (35%; 95% confidence intervals [CI] 20.2%-52.5%) rated their overall pain status as significantly improved, 22 (60%; 95% CI 42.1%-75.3%) as a little improved or unchanged, and two patients (5%; 95% CI 0.7%-18.2%) as worse. Five patients (14%; 95% CI 4.5%-28.8%) were pain-free, indicated by a characteristic pain intensity score of 0. Average pain intensity decreased (from 5.7 ± 2.0 to 3.5 ± 2.4; P < .001). Pain frequency (P < .001) and GCPS (P < .001) also decreased, whereas SCL-90R scores remained unchanged and 26 of the 37 patients reported ongoing treatment. Low baseline pain intensity was the only factor predictive of favorable outcome.
Conclusion: A third of the AO patients improved considerably over time, but for many of the patients, AO was a persistent and treatment-resistant condition.